Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Mathias Sheila | 0001991182 | Sep-27-2023 | officer: Chief Scientific Officer |
Shah Vinay | 0001753078 | Jun-20-2023 | officer: Chief Financial Officer |
Ruskin Barbara | 0001969041 | Mar-24-2023 | director |
Dubin Michael F | 0001876497 | Jul-26-2021 | director |
JACOB GARY S | 0001266802 | Apr-07-2021 | director |
Chipman Christopher Michael | 0001354941 | Apr-07-2021 | officer: Chief Financial Officer |
Singh Vanila | 0001795397 | Apr-07-2021 | director |
Gudin Jeffrey | 0001818449 | Apr-07-2021 | director, officer: Chief Medical Officer |
Jambulingam Thani | 0001818466 | Apr-07-2021 | director |
Floyd Eric | 0001818469 | Apr-07-2021 | director |
Sendrow Jerrold | 0001818472 | Apr-07-2021 | director |
Mack Anthony P. | 0001818483 | Apr-07-2021 | director, 10 percent owner, officer: Chief Executive Officer |
Bruce Gerald W | 0001361013 | Feb-16-2021 | officer: EVP, Commercial Operations |
Virpax Pharmaceuticals LLC | 0001842247 | Feb-16-2021 | 10 percent owner |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Virpax Pharmaceuticals, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
S-1/A | Document | Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001213900-24-036727 (33 Act) Size: 827 KB |
Apr-26-2024 | 24885269 |
S-1 | Document | General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001213900-24-034117 (33 Act) Size: 997 KB |
Apr-18-2024 | 24854505 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001213900-24-030808 (33 Act) Size: 105 KB |
Apr-05-2024 | 24826489 |
8-K | Document | Current report filing Acc-no: 0001213900-24-029811 (34 Act) Size: 196 KB |
Apr-03-2024 | 24818695 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-24-025781 (34 Act) Size: 6128 KB |
Mar-26-2024 | 24780988 |
8-K | Document | Current report filing Acc-no: 0001213900-24-025754 (34 Act) Size: 269 KB |
Mar-26-2024 | 24780896 |
8-K | Document | Current report filing Acc-no: 0001213900-24-023188 (34 Act) Size: 198 KB |
Mar-18-2024 | 24756870 |
8-K | Document | Current report filing Acc-no: 0001213900-24-018995 (34 Act) Size: 337 KB |
Mar-01-2024 | 24709597 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-008463 ( Act) Size: 11 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-008459 ( Act) Size: 11 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-008456 ( Act) Size: 11 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-008455 ( Act) Size: 11 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-008454 ( Act) Size: 11 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-008452 ( Act) Size: 11 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-008450 ( Act) Size: 11 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-008448 ( Act) Size: 11 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-008447 ( Act) Size: 11 KB |
Jan-31-2024 | |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001535610-24-000003 (34 Act) Size: 12 KB |
Jan-02-2024 | 24500752 |
8-K | Document | Current report filing Acc-no: 0001213900-23-099431 (34 Act) Size: 204 KB |
Dec-29-2023 | 231524294 |
8-K | Document | Current report filing Acc-no: 0001213900-23-095247 (34 Act) Size: 196 KB |
Dec-13-2023 | 231483037 |
Recent 20 filings. View all Virpax Pharmaceuticals, Inc. filings
young lad who new his job ansered questions and new what was best for me.
Very good communication and delivery made within the timeframe I was advised of
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by